Expression of the human p55 and p75 tumor necrosis factor receptors in primary villous trophoblasts and their role in cytotoxic signal transduction

Biology of Reproduction

Volumn 55, Issue 2, 1996, Pages 400-409

  Yui, Jane ^b   Hemmings, Denise ^a   Garcia Lloret, Maria ^a   Guilbert, Larry J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RECEPTOR ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; CYTOTROPHOBLAST; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

EID: 0029741882     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod55.2.400     Document Type: Article

References (54)

1. Beutler B, Cerami A. The biology of cachetin/TNF-α: primary mediator of the host response. Annu Rev Immunol 1989; 7:625-655.
2. Fiers W. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett 1991; 285:199-212.
3. Loetscher H, Pan Y-C E, Lahm H-W, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 1990; 61:351-359.
4. Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 1990; 248:1019-1023.
5. Schal T, Lewis M, Koller KJ, Lee A, Rice GC, Wong GHW, Gatanaga T, Granger GA, Lentz R, Raab H, Kohr WJ, Goeddel DV. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 1990; 61:361-370.
6. Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994; 76:959-962.
7. Beutler B, van Huffel C. Unraveling function in the TNF ligand and receptor families. Science 1994; 264:667-668.
8. Chen H-L, Yang Y, Hu X-L, Yelavarthi KK, Fishback JL, Hunt JS. Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Pathol 1991; 139:327-335.
9. Haynes MK, Jackson LG, Tuan RS, Shepley KJ, Smith B. Cytokine production in first trimester chorionic villi: detection of mRNAs and protein products in situ. Cell Immunol 1993; 151:300-308.
10. Yang Y, Yelavarthi KK, Chen H-L, Pace JL, Terranova PF, Hunt JS. Molecular, biochemical, and functional characteristics of tumor necrosis factor-α produced by human placental cytotrophoblastic cells. J Immunol 1993; 150:5614-5624.
11. Chaouat G, Menu E, Clark DA, Dy M, Minkowski M, Wegmann TG. Control of fetal survival in CBA × DBA/2 mice by lymphokine therapy. J Reprod Fertil 1990; 89:447-458.
12. Yui J, Garcia-Lloret M, Wegmann TG, Guilbert LJ. Cytotoxicity of tumor necrosis factor alpha and gamma-interferon against primary human placental trophoblasts. Placenta 1994; 15:819-835.
13. Garcia-Lloret MI, Yui J, Winkler-Lowen B, Guilbert LJ. Epidermal growth factor inhibits cytokine-induced apoptosis of primary human trophoblasts. J Cell Physiol 1996; 167:324-332.
14. Yelavarthi KK, Hunt JS. Analysis of p60 and p80 tumor necrosis factor-α receptor messenger RNA and protein in human placentas. Am J Pathol 1993; 143:1131-1141.
15. Eades DK, Cornelius P, Pekala PH. Characterization of the tumor necrosis factor receptor in human placenta. Placenta 1988; 9:247-251.
16. Hampson J, Mclaughlin PJ, Johnson PM. Low-affinity receptors for tumor necrosis factor-α, interferon-γ and granulocyte-macrophage colony-stimulating factor are expressed on human placental syncytiotrophoblast. Immunology 1993; 79:485-490.
17. Greenblatt MS, Elias L. The type B receptor for tumor necrosis factor-α mediates DNA fragmentation in HL-60 and U937 cells and differentiation in HL-60 cells. Blood 1992; 80:1339-1346.
18. Wiegmann K, Schutze S, Kampen E, Himmler A, Machleidt T, Kronke M. Human 55-kDa receptor for tumor necrosis factor coupled to signal transduction cascades. J Biol Chem 1992; 267:17997-18001.
19. Loetscher H, Steuber D, Banner D, Mackay F, Lesslauer W. Human tumor necrosis factor a (TNFα) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors. J Biol Chem 1993; 268:26350-26357.
20. Tartaglia LA, Pennica D, Goeddel DV. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 1993; 268:18542-18548.
21. Barbara JAJ, Smith WB, Gamble J, van Ostade X, Vandenabeele P, Tavernier J, Fiers W, Vadas MA, Lopez AF. Dissociation of TNF-α cytotoxic and proinflammatory activities by p55 receptor- and p75 receptor-selective TNF-α mutants. EMBO J 1994; 13:843-850.
22. Shalaby MR, Sundan A, Loetscher H, Brockhaus M, Lesslauer W, Espevik T. Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors. J Exp Med 1990; 172:1517-1520.
23. Heller RA, Song K, Fan N, Chang D. The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 1992; 70:47-56.
24. Higuchi M, Aggarwal BB. Differential roles of two types of TNF receptors in TNF-induced cytotoxicity, DNA fragmentation, and differentiation. J Immunol 1994; 152:4017-4025.
25. Yui J, Garcia-Lloret M, Brown AJ, Berdan RC, Morrish DW, Wegmann TG, Guilbert LJ. Functional, long-term cultures of human term trophoblasts purified by column-elimination of CD9 expressing cells. Placenta 1994; 15:231-246.
26. Morrish DW, Marusyk H, Siy O. Demonstration of specific secretory granules for human chorionic gonadotropin in placenta. J Histochem Cytochem 1987; 35:93-101.
27. van Ostade X, Vandenabeele P, Everaerdt B, Loetscher H, Gentz R, Brockhaus M, Lesslauer W, Tavernier J, Brouckaert P, Fiers W. Human TNF mutants with selective activity on the p55 receptor. Nature 1993; 361:266-268.
28. Brockhaus M, Schoenfeld H-J, Schlager EJ, Hunziker W, Lesslauer W, Loetscher H. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 1990, 87:3127-3131.
29. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55-63.
30. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119:493-501.
31. Green MA, Sviland L, Malcalm AJ, Pearson ADJ. Improved method for immunoperoxidase detection of membrane antigens in frozen sections. J Clin Pathol 1989; 42:875-880.
32. Bykrit DR. Statistics Today: A Comprehensive Introduction. Menlo Park: The Benjamin/Cummings Publishing Company, Inc.; 1987: 687-689.
33. Espevik T, Brockhaus M, Loetscher H, Nonstad U, Shalaby R. Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor. J Exp Med 1990; 171: 415-426.
34. Yanaga F, Watson SP. Tumor necrosis factor α stimulates sphingomyelinase through the 55 kDa receptor in HL-60 cells. FEBS Lett 1992; 314:297-300.
35. Nedospasov SA, Shakov AN, Turetskaya RL, Mett VA, Azizov MM, Geogiev GP, Korobko VG, Dobrynin VN, Filippov SA, Bystrov NS, Boldyreva EF, Chuvpilo SA, Chumakov AM, Ovchinnikov YA. Tandem arrangements of genes coding for tumor necrosis factor (TNF-α) and lymphotoxin (TNF-β) in the human genome. Cold Spring Harbor Symp Quant Biol 1986; 511:611-624.
36. Hohmann H-p, Brockhaus M, Baeuerle PA, Remy R, Kolbec R, van Loon APGM. Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-κB. J Biol Chem 1990; 265:14497-14504.
37. Philip R, Epstein LB. Tumor necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1. Nature 1986; 323:86-89.
38. Vince G, Shorter S, Starkey P, Humphreys J, Clover L, Wilkins T, Sargent I, Redman C. Localization of tumor necrosis factor production in cells at the materno/fetal interface in human pregnancy. Clin Exp Immunol 1992; 88:174-180.
39. Mackay F, Loetscher H, Stueber D, Gehr G, Lesslauer W. Tumor necrosis factor α (TNF-α)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med 1993; 177:1277-1286.
40. Tartaglia LA, Ayres TM, Wong GHW, Goeddel DV. A novel domain within the 55 kd TNF receptor signals cell death. Cell 1993; 74:845-853.
41. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S-I, Sameshima M, Hase A, Seto Y, Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen fas can mediate apoptosis. Cell 1991; 66:233-243.
42. Jarvis WD, Kolesnick RN, Fornari FA, Traylor RS, Gewirtz DA, Grant S. Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci USA 1994; 91:73-77.
43. Mangan DF, Wahl SM. Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and proinflammatory cytokines. J Immunol 1991; 147:3408-3412.
44. Bradley JR, Thiru S, Pober JS. Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells. Am J Pathol 1995; 146:27-32.
45. Clement M-V, Stamenkovic I. Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions. J Exp Med 1994; 180:557-567.
46. Austgulen R, Liabakk N-B, Brockhaus M, Espevik T. Soluble TNF receptors in amniotic fluid and in urine from pregnant women. J Reprod Immunol 1992; 22:105-116.
47. Austgulen R, Liabakk N-B, Lien E, Espevik T. Increased levels of soluble tumor necrosis factor-α receptors in serum from pregnant women and in serum and urine samples from newborns. Pediatr Res 1993; 33:82-87.
48. Haddad EK, Duclos AJ, Baines MG. Early embryo loss is associated with local production of nitric oxide by decidual mononuclear cells. J Exp Med 1995; 182:1143-1151.
49. Chwalisz K, Benson M, Scholz P, Daum J, Beier HM, Hegele-Hartung C. Cervical ripening with the cytokines interleukin 8, interleukin 1 beta and tumour necrosis factor alpha in guinea-pigs. Hum Reprod 1994; 9:2173-2181.
50. Kelly RW. Pregnancy maintenance and parturition: the role of prostaglandin in manipulating the immune and inflammatory response. Endocr Rev 1994; 15:684-706.
51. Krishnan L, Guilbert LJ, Russell AS, Wegmann TG, Mosmann TR, Belosevic M. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-γ responses and increased production of T-helper 2 cytokines. J Immunol 1996; 156:644-652.
52. Krishnan L, Guilbert LJ, Wegmann TG, Belosevic M, Mosmann TR. The TH1 response against Leishmania Major in pregnant C57BL/6 mice increases implantation failure and fetal resorptions: correlation with increased IFNγ and TNF and reduced IL10 production by placental cells. J Immunol 1996; 156:653-662.
53. Holland D, Bretscher P, Russell AS. Immunologic and inflammatory responses during pregnancy. J Clin Lab Immunol 1984; 14:177-179.
54. Wegmann TG, Hui L, Guilbert LJ, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 1993; 14:353-356.